| Etiological role of viruses in outbreaks of acute gastroenteritis in The Netherlands from 1994 through 2005 S Svraka, E Duizer, H Vennema, E de Bruin, B van der Veer, B Dorresteijn, ... Journal of clinical microbiology 45 (5), 1389-1394, 2007 | 415 | 2007 |
| Nanobody-based cancer therapy of solid tumors M Kijanka, B Dorresteijn, S Oliveira, PMP van Bergen en Henegouwen Nanomedicine 10 (1), 161-174, 2015 | 302 | 2015 |
| Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients S Kurk, P Peeters, R Stellato, B Dorresteijn, P de Jong, M Jourdan, ... Journal of cachexia, sarcopenia and muscle 10 (4), 803-813, 2019 | 79 | 2019 |
| Hypoxia-targeting fluorescent nanobodies for optical molecular imaging of pre-invasive breast cancer ASA van Brussel, A Adams, S Oliveira, B Dorresteijn, M El Khattabi, ... Molecular Imaging and Biology 18, 535-544, 2016 | 68 | 2016 |
| Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients SA Kurk, PHM Peeters, B Dorresteijn, PA de Jong, M Jourdan, HJ Kuijf, ... Journal of cachexia, sarcopenia and muscle 9 (5), 909-919, 2018 | 55 | 2018 |
| Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice KT Xenaki, B Dorresteijn, JA Muns, K Adamzek, S Doulkeridou, ... Theranostics 11 (11), 5525, 2021 | 43 | 2021 |
| A novel immuno-gold labeling protocol for nanobody-based detection of HER2 in breast cancer cells using immuno-electron microscopy M Kijanka, EG Van Donselaar, WH Müller, B Dorresteijn, ... Journal of Structural Biology 199 (1), 1-11, 2017 | 36 | 2017 |
| Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: secondary analysis of the phase 3 CAIRO3 trial SA Kurk, PHM Peeters, B Dorresteijn, PA de Jong, M Jourdan, ... Cancer medicine 9 (3), 1033-1043, 2020 | 29 | 2020 |
| The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer JWG Derksen, SA Kurk, PHM Peeters, B Dorresteijn, M Jourdan, ... Journal of cachexia, sarcopenia and muscle 11 (4), 919-928, 2020 | 22 | 2020 |
| Camelid heavy chain only antibody fragment domain against β‐site of amyloid precursor protein cleaving enzyme 1 inhibits β‐secretase activity in vitro and in vivo B Dorresteijn, M Rotman, D Faber, R Schravesande, E Suidgeest, ... The FEBS Journal 282 (18), 3618-3631, 2015 | 21 | 2015 |
| Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients SA Kurk, RK Stellato, PHM Peeters, B Dorresteijn, M Jourdan, MJ Oskam, ... The American journal of clinical nutrition 110 (6), 1395-1403, 2019 | 18 | 2019 |
| Specialized nutrition improves muscle function and physical activity without affecting chemotherapy efficacy in C26 tumour‐bearing mice LA Wijler, DAE Raats, SG Elias, FJ Dijk, H Quirindongo, AM May, ... Journal of cachexia, sarcopenia and muscle 12 (3), 796-810, 2021 | 10 | 2021 |
| DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells FJ Dijk, M Van Dijk, B Dorresteijn, K Van Norren Oncotarget 10 (57), 5983, 2019 | 8 | 2019 |
| van Bergen en, Henegouwen PM M Kijanka, B Dorresteijn, S Oliveira Nanobody-based cancer therapy of solid tumors, Nanomedicine (Lond) 10, 161-174, 2015 | 8 | 2015 |
| Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients. J Cachexia Sarcopenia Muscle. 2019; 10 (4): 803–13 S Kurk, P Peeters, R Stellato, B Dorresteijn, P de Jong, M Jourdan Přejít k původnímu zdroji... Přejít na PubMed, 0 | 7 | |
| Construction of novel bispecific single-domain antibodies (BiSdAbs) with potent antiangiogenic activities X Liu, T Sun, Q Ge, J Zhu Pharmaceutical Fronts 2 (01), e64-e76, 2020 | 6 | 2020 |
| Extremely thin layer plastification for focused‐ion beam scanning electron microscopy: an improved method to study cell surfaces and organelles of cultured cells EG Van Donselaar, B Dorresteijn, D Popov‐Čeleketić, ... Journal of Microscopy 270 (3), 359-373, 2018 | 6 | 2018 |
| Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients. J Cachexia Sarcopenia Muscle 2018; 9: 909e19 SA Kurk, PHM Peeters, B Dorresteijn, PA de Jong, M Jourdan, HJ Kuijf, ... J Thorac Oncol 13 (7), 895-903, 2018 | 5 | 2018 |
| Impact of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) on time to progression and overall survival (OS) in metastatic colorectal cancer (mCRC … S Kurk, PHM Peeters, RK Stellato, B Dorresteijn, M Jourdan, GJ Creemers, ... Journal of Clinical Oncology 35 (15_suppl), 10087-10087, 2017 | 5 | 2017 |
| Whey-based diet containing medium chain triglycerides modulates the gut microbiota and protects the intestinal mucosa from chemotherapy while maintaining therapy efficacy HR Wardill, AR Da Silva Ferreira, H Kumar, EH Bateman, CB Cross, ... Cell Death & Disease 14 (5), 338, 2023 | 4 | 2023 |
